Community Practice Connections™: 18th Annual New York GU Cancer Congress™

Release Date: June 30, 2025

Expiration Date: June 30, 2026

Activity Overview

This Community Practice Connection™ program provides an in-depth review of some highlights from the 18th Annual New York GU Cancers Congress™ held in March 2025. This unique and engaging multimedia activity is ideal for community-based clinicians and focuses on the practical aspects of managing patients with prostate, bladder, and renal cell cancer, helping clinicians to place recent clinical trial data into context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with genitourinary (GU) malignancies. Urologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, nuclear medicine physicians, and other health care professionals interested in treating GU malignancies may also participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Identify key diagnostic, prognostic, and therapeutic biomarkers that inform evidence-based treatment strategies for GU cancers.
• Evaluate emerging safety and efficacy data from recently reported clinical trials on novel therapeutic strategies in GU malignancies.
• Assess the impact of recent landmark clinical trial data on the standards of care for the treatment of GU malignancies.
• Determine effective strategies to monitor and mitigate adverse events associated with systemic therapies in GU cancer care.